Latest filing published 22 May 2025 for Macrogenics INC.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Ferrante Karen Jean: trading record in brief
This profile gathers the share dealings of Ferrante Karen Jean across 3 companies, led by HUTCHMED (China) Ltd., Baxalta Inc and Macrogenics Inc. Over a trading history stretching from 27 July 2015 to 20 May 2025, the count stands at 10 filings.
No open-market sale appears; the market trades are 1 purchase. The totals exclude 1 filing filed without an amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 2 share grants and 2 option exercises.
The record was last updated on 22 May 2025 with an option exercise in Macrogenics Inc. The latest purchase dates back some time: it was published 1,833 days ago, on 2 November 2021. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Ferrante Karen Jean
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 6,500 sharesCommon StockSEC:0001125345-25-000080:0
- 4,500 shares0Common StockSEC:0001125345-24-000102:0
- 11,985 sharesShareXHKGHKEX:DA20230421E00292
- 8,235 sharesShareXHKGHKEX:DA20221021E00411
- 11,985 sharesShareXHKGHKEX:DA20220425E00024
- 32,940 sharesShareXHKGHKEX:DA20211102E00203Canonical exit: 26 Jan 2022 (T+90)
- 76,865 sharesShareXHKGHKEX:DA20210714E00332
- 7,657 sharesCommon Stock, $0.01 par valueSEC:0000899243-16-021945:0
- 4,500 sharesCommon Stock, $0.01 par valueSEC:0000899243-16-019807:0
- 3,140 shares0Common Stock, par value $0.01 per shareSEC:0000899243-15-001869:0
10 of 10 declarations
